Drug Profile
Research programme: hepatitis B virus vaccines - Vir Biotechnology
Latest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator Oregon Health & Science University; TomegaVax
- Developer Oregon Health & Science University; Vir Biotechnology
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Hepatitis-B in USA (Parenteral)
- 09 Aug 2016 Early research in Hepatitis B in USA (Parenteral)